The effect of Padzahr tablets on the symptoms of COVID-19
Phase 2
- Conditions
- COVID-19.COVID-19U07.1
- Registration Number
- IRCT20131129015584N4
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
Probable diagnosis of COVID-19 based on national Iranian protocol
Exclusion Criteria
Late 5 days from the onset of symptoms
Existence of comorbidity
Pregnancy and lactation
history of Allergy
Complicated with bacterial infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever reduction time. Timepoint: Time to start reducing fever after the intervention. Method of measurement: hour.;Fever intensity. Timepoint: All days of hospitalization. Method of measurement: C.;Blood oxygen saturation. Timepoint: All days after the intervention. Method of measurement: Pulse oximetry.
- Secondary Outcome Measures
Name Time Method Duration of hospital stay. Timepoint: Patient discharge time. Method of measurement: day.